122 related articles for article (PubMed ID: 36369416)
1. High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review.
Satragno C; Verrico A; Giannelli F; Ferrero A; Campora S; Turazzi M; Cavagnetto F; Schiavetti I; Garrè ML; Garibotto F; Milanaccio C; Piccolo G; Crocco M; Ramaglia A; Di Profio S; Barra S; Belgioia L
J Neurooncol; 2022 Dec; 160(3):659-668. PubMed ID: 36369416
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
[TBL] [Abstract][Full Text] [Related]
4. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
5. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
Irikura T; Fukuoka K; Nakazawa A; Ichimura K; Kurihara J; Koh K
Childs Nerv Syst; 2023 Sep; 39(9):2505-2507. PubMed ID: 37185696
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
Smith SMC; Bianski BM; Orr BA; Harknett G; Onar-Thomas A; Gilbertson RJ; Merchant TE; Roussel MF; Tinkle CL
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):728-737. PubMed ID: 30366006
[TBL] [Abstract][Full Text] [Related]
8. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
[TBL] [Abstract][Full Text] [Related]
9. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
10. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
Baroni LV; Freytes C; Fernández Ponce N; Oller A; Pinto N; Gonzalez A; Maldonado FR; Sampor C; Rugilo C; Lubieniecki F; Alderete D
J Neurooncol; 2021 Oct; 155(1):53-61. PubMed ID: 34505229
[TBL] [Abstract][Full Text] [Related]
11. Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K; Kurihara J; Shofuda T; Kagawa N; Yamasaki K; Ando R; Ishida J; Kanamori M; Kawamura A; Park YS; Kiyotani C; Akai T; Keino D; Miyairi Y; Sasaki A; Hirato J; Inoue T; Nakazawa A; Koh K; Nishikawa R; Date I; Nagane M; Ichimura K; Kanemura Y
Acta Neuropathol Commun; 2023 Sep; 11(1):153. PubMed ID: 37749662
[TBL] [Abstract][Full Text] [Related]
12. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
[TBL] [Abstract][Full Text] [Related]
13. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
14. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
Paulino AC
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
[TBL] [Abstract][Full Text] [Related]
16. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
[TBL] [Abstract][Full Text] [Related]
19. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
